DSGN
Design Therapeutics, Inc. Common StockRecent alerts on DSGN
All signals →
SEC filing
DSGN Reports $222.8M Cash, $17.6M Net Loss, Adds Board Member, Advances FA Trial, Pipeline Updates
34d ago
SEC filing
DSGN Reports $219.8M Cash, $13.4M Qtr R&D, $69.8M Yr Net Loss, Advances DT-216P2 FA, DT-168 FECD, DT-818 DM1 Trials
84d ago
News
Proficient Auto Logistics targets 150 basis points operating ratio improvement in 2026 amid market share gains and cost control
112d ago
News
Lilly Signs Seamless Gene-Editing Deal for Over $1.1 Billion
125d ago
Scanner
Unusual volume (z=12.1)
164d ago
Scanner
Unusual volume (z=5.1)
165d ago
Get push alerts for DSGN
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS